Contineum Therapeutics, Inc.
Total Trades
22
Buys
0
Sells
14
Largest Trade
$100K–$500K
Insiders
3
Institutional Funds
50
Inst. Value
$1M+
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Lorrain Daniel S. | Chief Scientific O… | SELL | $50K–$100K | 4K | $15.01 | Mar 2, 2026 |
| Watkins Tim | CMO & Head of Deve… | SELL | $50K–$100K | 4K | $15.02 | Mar 2, 2026 |
| Watkins Tim | CMO & Head of Deve… | EXERCISE | $15K–$50K | 4K | $4.50 | Mar 2, 2026 |
| Stengone Carmine N. | CEO and President | EXERCISE | $1K–$15K | 7K | $1.26 | Feb 26, 2026 |
| Stengone Carmine N. | CEO and President | SELL | $100K–$500K | 7K | $16.02 | Feb 26, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $100K–$500K | 8K | $16.02 | Feb 26, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | EXERCISE | $1K–$15K | 8K | $1.01 | Feb 26, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | EXERCISE | <$1K | 100 | $1.01 | Feb 20, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $1K–$15K | 100 | $16.00 | Feb 20, 2026 |
| Stengone Carmine N. | CEO and President | EXERCISE | <$1K | 400 | $1.26 | Feb 13, 2026 |
| Stengone Carmine N. | CEO and President | SELL | $1K–$15K | 400 | $16.00 | Feb 13, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | EXERCISE | <$1K | 400 | $1.01 | Feb 13, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $1K–$15K | 400 | $16.00 | Feb 13, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $50K–$100K | 4K | $14.94 | Feb 5, 2026 |
| Watkins Tim | CMO & Head of Deve… | SELL | $50K–$100K | 4K | $14.18 | Jan 30, 2026 |
| Watkins Tim | CMO & Head of Deve… | EXERCISE | $15K–$50K | 4K | $4.50 | Jan 30, 2026 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $15K–$50K | 4K | $10.44 | Jan 6, 2026 |
| Watkins Tim | CMO & Head of Deve… | EXERCISE | $15K–$50K | 4K | $4.50 | Dec 30, 2025 |
| Watkins Tim | CMO & Head of Deve… | SELL | $15K–$50K | 4K | $12.06 | Dec 30, 2025 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $50K–$100K | 4K | $12.23 | Dec 30, 2025 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $15K–$50K | 1K | $16.02 | Nov 27, 2024 |
| Lorrain Daniel S. | Chief Scientific O… | SELL | $100K–$500K | 6K | $16.38 | Nov 20, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 50 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 2.2M | $1M+ | SH |
| JOHNSON & JOHNSON | 2.0M | $1M+ | SH |
| FRANKLIN RESOURCES INC | 1.9M | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 1.8M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 1.5M | $1M+ | SH |
| VANGUARD GROUP INC | 1.1M | $1M+ | SH |
| SECTORAL ASSET MANAGEMENT INC | 801K | $1M+ | SH |
| Point72 Asset Management, L.P. | 759K | $1M+ | SH |
| HHLR ADVISORS, LTD. | 669K | $1M+ | SH |
| Red Tree Management, LLC | 638K | $1M+ | SH |
| Versant Venture Management, LLC | 543K | $1M+ | SH |
| Longaeva Partners L.P. | 470K | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308K | $1M+ | SH |
| Ikarian Capital, LLC | 283K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 279K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 279K | $1M+ | SH |
| UBS Group AG | 199K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 176K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 173K | $1M+ | SH |
| Monashee Investment Management LLC | 137K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
7.2%
2.2M shares
SC 13G · Feb 17, 2026
7.9%
2.4M shares
SC 13G/A · Jan 29, 2026
6.2%
1.9M shares
SC 13G/A · Nov 4, 2025
7.7%
1.7M shares
SC 13G/A · Aug 14, 2025
3.2%
699K shares
SC 13G/A · Aug 5, 2025
8.9%
1.7M shares
SC 13G · Jul 25, 2025
9.9%
2.1M shares
SC 13G/A · May 15, 2025
7.5%
1.4M shares
SC 13G/A · Feb 14, 2025
5.6%
1.4M shares
SC 13G/A · Feb 14, 2025
4.2%
801K shares
SC 13G · Nov 14, 2024
5.0%
951K shares
SC 13G · Oct 31, 2024
7.6%
1.4M shares
Suvretta Capital Management, LLC
SC 13G · Apr 15, 2024
9.3%
1.7M shares
SC 13G · Apr 15, 2024
8.5%
1.6M shares
SC 13G · Apr 10, 2024
10.7%
2.0M shares